GlassScriptPhysician profile
Amanda Deadmond
NPI 1053818583
$5,988.85
in general payments reported to CMS, 2019-2025
9 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.94 · 2024: $5,832 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,159 · Travel and Lodging: $2,473 · Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,159.42 |
| Travel and Lodging | $2,473.23 |
| Food and Beverage | $337.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,669.67 | 2024 | |
| Amgen INC. | $125.00 | 2024 | Evenity |
| Coopersurgical, INC. | $68.08 | 2025 | Ally II Ups |
| Astellas Pharma US INC | $38.52 | 2024-2025 | Veozah |
| Hologic Sales and Service, LLC | $29.62 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Evofem Biosciences, INC. | $28.30 | 2024-2025 | Phexxi, Solosec, Phexx |
| Abbvie INC. | $18.94 | 2022 | |
| Organon LLC | $5.75 | 2024 | |
| Meditrina | $4.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Deadmond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.